{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:19:44Z","timestamp":1785521984837,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02332-9","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T09:13:57Z","timestamp":1779700437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin dose up-titration and glycemic control in type 2 diabetes in a resource-limited setting, northern Ethiopia: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Gebrehiwot","family":"Teklay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halefom","family":"Tafere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirga Legesse","family":"Niriayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2332_CR1","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15-S33. https:\/\/doi.org\/10.2337\/dc21-S002. Erratum in: Diabetes Care. 2021;44(9):2182.","DOI":"10.2337\/dc21-S002"},{"key":"2332_CR2","unstructured":"WHO. Diabetes. who.int\/health-topics\/diabetes#tab=tab_1. Accessed 27 Jul 2023."},{"key":"2332_CR3","unstructured":"WHO. Diagnosis and management of type 2 diabetes (HEARTS-D). Geneva]: World Health Organization. 2020 (WHO\/UCN\/NCD\/20.1). https:\/\/apps.who.int\/iris\/rest\/bitstreams\/1274478\/retrieve. Accessed 27 Jul 2023."},{"key":"2332_CR4","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021. Diabetes Care. 44(Suppl 1), S111-S124. 2021. https:\/\/doi.org\/10.2337\/dc21-S009.","DOI":"10.2337\/dc21-S009"},{"key":"2332_CR5","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil H. A.W. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577\u201389.","journal-title":"N Engl J Med"},{"issue":"11","key":"2332_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.7326\/M15-2650","volume":"164","author":"NM Maruthur","year":"2016","unstructured":"Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2016;164(11):740\u201351. https:\/\/doi.org\/10.7326\/M15-2650.","journal-title":"Ann Intern Med"},{"key":"2332_CR7","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. Glycemic, Targets: Standards of Medical Care in Diabetes-2021. Diabetes Care. 44(Suppl 1), S73-S84. 2021. https:\/\/doi.org\/10.2337\/dc21-S006.","DOI":"10.2337\/dc21-S006"},{"issue":"1","key":"2332_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2337\/dc08-9026","volume":"32","author":"JS Skyler","year":"2009","unstructured":"Skyler JS, American Diabetes Association; American College of Cardiology Foundation; American Heart Association, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32(1):187\u201392. https:\/\/doi.org\/10.2337\/dc08-9026.","journal-title":"Diabetes Care"},{"issue":"7","key":"2332_CR9","first-page":"799","volume":"65","author":"S Kalra","year":"2015","unstructured":"Kalra S, Gupta Y. Starting titrating and intensifying metformin. J Pak Med Assoc. 2015;65(7):799\u2013800.","journal-title":"J Pak Med Assoc"},{"issue":"10","key":"2332_CR10","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.2337\/dc17-0662","volume":"41","author":"U Desai","year":"2018","unstructured":"Desai U, et al. Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes. Diabetes Care. 2018;41(10):2096\u2013104. https:\/\/doi.org\/10.2337\/dc17-0662.","journal-title":"Diabetes Care"},{"key":"2332_CR11","doi-asserted-by":"publisher","first-page":"117955142110305","DOI":"10.1177\/11795514211030513","volume":"13","author":"AK Das","year":"2021","unstructured":"Das AK, et al. Real-World Clinical Experience on the Usage of High-Dose Metformin (1500\u20132500\u00a0mg\/day) in Type 2 Diabetes Management. Clin Med Insights Endocrinol Diabetes. 2021;13:14:11795514211030513. https:\/\/doi.org\/10.1177\/11795514211030513.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"5","key":"2332_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2337\/dc19-1769","volume":"43","author":"WI Sivitz","year":"2020","unstructured":"Sivitz WI, et al. Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. Diabetes Care. 2020;43(5):940\u20137. https:\/\/doi.org\/10.2337\/dc19-1769.","journal-title":"Diabetes Care"},{"issue":"1","key":"2332_CR13","doi-asserted-by":"publisher","first-page":"e00107","DOI":"10.1002\/edm2.107","volume":"3","author":"K Iglay","year":"2019","unstructured":"Iglay K, et al. Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetes. Endocrinol Diabetes Metab. 2019;3(1):e00107. https:\/\/doi.org\/10.1002\/edm2.107.","journal-title":"Endocrinol Diabetes Metab"},{"key":"2332_CR14","doi-asserted-by":"publisher","first-page":"117955142110305","DOI":"10.1177\/11795514211030513","volume":"13","author":"AK Das","year":"2021","unstructured":"Das AK, et al. Real-World Clinical Experience on the Usage of High-Dose Metformin (1500\u20132500\u00a0mg\/day) in Type 2 Diabetes Management. Clin Med Insights Endocrinol Diabetes. 2021;13:14:11795514211030513. https:\/\/doi.org\/10.1177\/11795514211030513.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"3","key":"2332_CR15","doi-asserted-by":"publisher","first-page":"e0282962","DOI":"10.1371\/journal.pone.0282962","volume":"18","author":"AL Dimore","year":"2023","unstructured":"Dimore AL, Edosa ZK, Mitiku AA. Glycemic control and diabetes complications among adult type 2 diabetic patients at public hospitals in Hadiya zone, Southern Ethiopia. PLoS ONE. 2023;18(3):e0282962. https:\/\/doi.org\/10.1371\/journal.pone.0282962.","journal-title":"PLoS ONE"},{"issue":"1","key":"2332_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12902-022-00974-z","volume":"22","author":"RG Abera","year":"2022","unstructured":"Abera RG, Demesse ES, Boko WD. Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study. BMC Endoc r Disord. 2022;22(1):54. https:\/\/doi.org\/10.1186\/s12902-022-00974-z.","journal-title":"BMC Endoc r Disord"},{"issue":"3","key":"2332_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/21623945.2018.1467716","volume":"7","author":"S Mideksa","year":"2018","unstructured":"Mideksa S, Ambachew S, Biadgo B, Baynes HW. Glycemic control and its associated factors among diabetes mellitus patients at Ayder comprehensive specialized hospital. Mekelle-Ethiopia Adipocyte. 2018;7(3):197\u2013203. https:\/\/doi.org\/10.1080\/21623945.2018.1467716.","journal-title":"Mekelle-Ethiopia Adipocyte"},{"key":"2332_CR18","unstructured":"Ayder Comprehensive Specialized Hospital. https:\/\/ayder.info\/index.php\/about-us. Accessed 08 January 2019."},{"issue":"7","key":"2332_CR19","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1742-1241.2009.02094.x","volume":"63","author":"JR Maclean","year":"2009","unstructured":"Maclean JR, Chapman RH, Ferrufino CP, Krishnarajah G. Drug titration patterns and HbA 1c levels in type 2 diabetes. Int J Clin Pract. 2009;63(7):1008\u201316. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02094.x.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2332_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2337\/cd21-0043","volume":"40","author":"IH Vieira","year":"2022","unstructured":"Vieira IH, Barros LM, Baptista CF, Rodrigues DM, Paiva IM. Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes. Clin Diabetes. 2022;40(1):97\u2013107. https:\/\/doi.org\/10.2337\/cd21-0043. PMID: 35221479; PMCID: PMC8865803.","journal-title":"Clin Diabetes"},{"issue":"4","key":"2332_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jppr.1812","volume":"52","author":"JA Wong","year":"2022","unstructured":"Wong JA, Young I, Sim R, Kua KP, Lee SWH. Type 2 diabetes mellitus treatment intensification and deintensification in primary care: a retrospective cohort study. J Pharm Pract Res. 2022;52(4):311\u20137. https:\/\/doi.org\/10.1002\/jppr.1812. (2022).","journal-title":"J Pharm Pract Res"},{"key":"2332_CR22","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2147\/PPA.S211614","volume":"13","author":"JH Flory","year":"2019","unstructured":"Flory JH, Keating S, Guelce D, Mushlin AI. Overcoming barriers to the use of metformin: patient and provider perspectives. Patient Prefer Adherence. 2019;13:1433\u201341. https:\/\/doi.org\/10.2147\/PPA.S211614.","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"2332_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.25122\/jml-2021-0259","volume":"15","author":"D Al-Waeli","year":"2022","unstructured":"Al-Waeli D, Mohammed A, Tahir I, Al-Saeedi A, Razzaq K, Abodhurais A. Barriers against the use of an optimal dose of metformin among patients with T2DM in Thi-Qar province, Iraq. J Med Life. 2022;15(4):557\u201362. https:\/\/doi.org\/10.25122\/jml-2021-0259.","journal-title":"J Med Life"},{"issue":"9","key":"2332_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4297\/najms.2011.3418","volume":"3","author":"NT Wabe","year":"2011","unstructured":"Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011;3(9):418\u201323. https:\/\/doi.org\/10.4297\/najms.2011.3418.","journal-title":"N Am J Med Sci"},{"issue":"3","key":"2332_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/jdi.12755","volume":"9","author":"K Kanto","year":"2017","unstructured":"Kanto K, et al. Effects of dosage and dosing frequency on the efficacy and safety of high-dose metformin in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig. 2017;9(3):587\u201393. https:\/\/doi.org\/10.1111\/jdi.12755.","journal-title":"J Diabetes Investig"},{"issue":"2","key":"2332_CR26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2337\/dc11-1465","volume":"35","author":"JA Hirst","year":"2012","unstructured":"Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ. Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care. 2012;35(2):446\u201354. https:\/\/doi.org\/10.2337\/dc11-1465.","journal-title":"Diabetes Care"},{"key":"2332_CR27","unstructured":"Federal Democratic Republic of Ethiopia Ministry of Health. Standard Treatment Guidelines for General Hospitals. 4th ed. Addis Ababa: FDRE MoH. 2021. Available at: https:\/\/hakimethio.org\/wp-content\/uploads\/2024\/09\/STG_4th_edition_2021_with_ToC-1.pdf"},{"issue":"10","key":"2332_CR28","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.4103\/0366-6999.156735","volume":"128","author":"XL Cai","year":"2015","unstructured":"Cai XL, et al. Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trial. Chin Med J (Engl). 2015;128(10):1279\u201387. https:\/\/doi.org\/10.4103\/0366-6999.156735.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"2332_CR29","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.clinthera.2005.10.012","volume":"27","author":"CJ Bailey","year":"2005","unstructured":"Bailey CJ, et al. Rosiglitazone\/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study. Clin Ther. 2005;27(10):1548\u201361. https:\/\/doi.org\/10.1016\/j.clinthera.2005.10.012.","journal-title":"Clin Ther"},{"issue":"18","key":"2332_CR30","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1080\/14656566.2017.1404576","volume":"18","author":"L Suzuki","year":"2017","unstructured":"Suzuki L, et al. Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin. Expert Opin Pharmacother. 2017;18(18):1921\u20138. https:\/\/doi.org\/10.1080\/14656566.2017.1404576.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"2332_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/pop.2018.0158","volume":"22","author":"R Mahabaleshwarkar","year":"2019","unstructured":"Mahabaleshwarkar R, Liu TL, Mulder H. Comparative Effectiveness of Metformin Dosage Uptitration Versus Adding Another Antihyperglycemic Medication on Glycemic Control in Type 2 Diabetes Patients Failing Initial Metformin Monotherapy: A Retrospective Cohort Study. Popul. Health Manag. 2019;22(5):457\u201363. https:\/\/doi.org\/10.1089\/pop.2018.0158.","journal-title":"Health Manag"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02332-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02332-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02332-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:10:11Z","timestamp":1785517811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02332-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2332"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02332-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was obtained from the Department of Pharmacy Research and Ethics Review Committee (approval number: CHS\/545\/phar-12). As the study was conducted only through review of medical records, participants were not available to give consent. However, data were collected after obtaining written permission from the medical director of ACSH and the study aims were discussed with staff members of the diabetic clinic. The collected data was kept confidential. All methods included in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the Helsinki Declaration of 1964, and its later amendments.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"215"}}